Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?

NCT02227264 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT02227264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02227264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?
Lead sponsor
Karolinska University Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2014
Completion date
December 31, 2021
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary hyperparathyroidism